Abstract:Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder. Affecting 5%-10% 1 Li R. Zhang Q. Yang D. Li S. Lu S. Wu X. et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013; 28: 2562-2569 Crossref PubMed Scopus (188) Google Scholar of reproductive-aged women, PCOS is characterized by hyperandrogenemia, anovulation, and insulin resistance (IR), with long-term effects throughout the different stages of a woman's life. During gestation, women with PCOS have greater androgen concentrations. 2 Sir-Petermann T. Maliqueo M. Angel B. Lara H.E. Perez-Bravo F. Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002; 17: 2573-2579 Crossref PubMed Google Scholar Intrauterine exposure to high androgen concentrations may cause fetal reprogramming or placental changes through epigenetic regulation or other mechanisms, thus causing changes in multiple systems in the offspring and ultimately affecting growth and development. The hormonal and metabolic alterations have been found in brothers of women with PCOS, 3 Sam S. Coviello A.D. Sung Y.A. Legro R.S. Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008; 31: 1237-1241 Crossref PubMed Scopus (45) Google Scholar ,4 Torchen L.C. Kumar A. Kalra B. Savjani G. Sisk R. Legro R.S. et al. Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016; 106: 50-55 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar which may reflect the effects of PCOS susceptibility genes or programming effects of the intrauterine environment. Furthermore, a greater risk of pregnancy complications, 5 Palomba S. de Wilde M.A. Falbo A. Koster M.P. La Sala G.B. Fauser B.C. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015; 21: 575-592 Crossref PubMed Scopus (163) Google Scholar , 6 Damm P. Houshmand-Oeregaard A. Kelstrup L. Lauenborg J. Mathiesen E.R. Clausen T.D. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016; 59: 1396-1399 Crossref PubMed Scopus (182) Google Scholar , 7 Walker C.K. Krakowiak P. Baker A. Hansen R.L. Ozonoff S. Hertz-Picciotto I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr. 2015; 169: 154-162 Crossref PubMed Scopus (136) Google Scholar the use of metformin during pregnancy, 8 Rowan J.A. Rush E.C. Plank L.D. Lu J. Obolonkin V. Coat S. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018; 6: e000456 Crossref PubMed Google Scholar and maternal metabolic abnormalities (including obesity or IR 9 Drake A.J. Reynolds R.M. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction. 2010; 140: 387-398 Crossref PubMed Scopus (278) Google Scholar ,10 Fusco S. Spinelli M. Cocco S. Ripoli C. Mastrodonato A. Natale F. et al. Maternal insulin resistance multigenerationally impairs synaptic plasticity and memory via gametic mechanisms. Nat Commun. 2019; 10: 4799 Crossref PubMed Scopus (0) Google Scholar ) may be implicated in the effects on offspring.

Understanding and Predicting Polycystic Ovary Syndrome through Shared Genetic Architecture with Testosterone, SHBG, and Inflammatory Markers

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study

Genomic and proteomic evidence for hormonal and metabolic foundations of polycystic ovary syndrome

Unveiling the shared genetic architecture between testosterone and polycystic ovary syndrome

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome

Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis

Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview

Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study

Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome

Identifying Novel Genetic Loci Associated with Polycystic Ovary Syndrome Based on Its Shared Genetic Architecture with Type 2 Diabetes.

Investigating the Role of Inflammatory Response in Polycystic Ovary Syndrome Using Integrated RNA-Seq Analysis

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome

Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome

Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment

Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins

Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome